{"id":"csl412","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CSL412 is a vaccine that works by stimulating the body's immune system to produce a specific response against the target pathogen.","oneSentence":"CSL412 is a vaccine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:50:11.784Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza prevention"}]},"trialDetails":[{"nctId":"NCT00479648","phase":"PHASE2","title":"A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants","status":"COMPLETED","sponsor":"Seqirus","startDate":"2007-05","conditions":"Influenza","enrollment":612}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CSL412","genericName":"CSL412","companyName":"Seqirus","companyId":"seqirus","modality":"Biologic","firstApprovalDate":"","aiSummary":"CSL412 is a vaccine. Used for Influenza prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}